Project Grant 2101278
Award Date
5/1/21
Completion Date
12/31/21
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Greensboro, NC 27401, USA
Similar Awards
Cobio Diagnostics Inc. received a $256,000 Project Grant award from the National Science Foundation on April 1, 2021 to support work concluding on March 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and education. Specifically, the grant funds Cobio Diagnostics' "SBIR PHASE I: PHAGE-AMPLIFIED IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST" project. This...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is focused on developing an affordable, portable virus detection platform. The $331,189 project, awarded on April 1, 2025 and running through March 31, 2028, integrates protein engineering and electrochemical biosensor technologies to create a virus detection system that can operate in resource-limited environments. The innovation lies in using stable...
Nanopath Inc. received a $255,874 Project Grant award from the National Science Foundation Division of Industrial Innovation on January 1, 2022 for its "Integrated Point-of-Care System for Rapid Pathogen Identification in Urinary Tract Infections" project. The award is part of the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and education. Under the award, Nanopath will develop an integrated...
Astek Diagnostics Inc. received a $255,975 Project Grant award from the National Science Foundation Division of Industrial Innovation on December 15, 2021 to support work completing August 31, 2022. The grant funds the development of rapid detection methods and determination of antibiotic resistance for blood-borne bacteria under the NSF Engineering program (CFDA 47.041). The Engineering program seeks to improve quality of life and economic strength by fostering innovation in engineering...
The National Science Foundation awarded a $294,100 project grant to the University of Kansas Medical Center Research Institute, Inc. to support research titled "EAGER: ENGINEERING OPTICAL NANOBIOSENSORS FOR DETECTION OF CORONAVIRUS PROTEASES" under the NSF Engineering program (CFDA 47.041). The grant funding will support the development of optical nanobiosensors for detecting coronavirus proteases from March 15, 2021 through October 31, 2022. The NSF Directorate for Engineering seeks...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Anvil Diagnostics Inc. in Cambridge, MA provides $298,646 to develop a rapid diagnostic test for detecting sepsis-causing pathogens in plasma samples. The proposed technology aims to comprehensively identify and quantify a wide range of pathogens from small blood volumes within 4 hours, addressing critical limitations of current sepsis diagnostics. The innovations focus on...
The National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded $800,000 under the Engineering (47.041) federal grant program to develop a novel biosynthetic toolkit for rapid detection and monitoring of COVID-19 antibodies. Funded from August 1, 2022 through July 31, 2025, Indiana University will construct SARS-CoV-2 epitope peptides fused with a nanotag transducer peptide and displayed on an RNA phage platform. This biosynthetic display aims...
This federal Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), supports the development of a rapid and automated pathogen DNA extraction device from venous whole blood samples. The $274,858 award, effective September 1, 2024 through February 28, 2025, will enable the awardee, New England Hemolytics, Inc., to test and optimize a novel pathogen extraction technology that can decrease the time to...
This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...